As we have done before for the guidelines of the French SFED, we are publishing an English translation of the recent German guideline on sedation. We will follow this practice occasionally with national guidelines of high quality. They will form the basis for an expansion of the ESGE guidelines which -under the direction of our board member Jean Marc Dumonceau -we will publish in the core part of our journal. Unified European guidelines are an integral part of the drive to bring our different national approaches in the field of endoscopy together.
Introduction

!
Background, rationale, and goals of the guideline
In the past few years, interest in sedation in gastrointestinal endoscopy has increased. It is currently the subject of much debate, some of it very lively. One major issue is the exact indication for sedation. Premedication is not necessary for all gastroenterological endoscopic interventions. Whether it is required depends on the nature of exam- Table 1 Guideline group: professional associations and organizations involved.
Professional society/task force/organization
Authors entitled to vote ination, its duration, its complexity, its invasiveness, and on the individual patient's characteristics. However, premedication can make the examination more comfortable for both the patient and the examining physician. Often it is premedication that makes a successful and low-risk examination possible. This is especially true for complex therapeutic interventions.
In the mid 1990s, sedation was much less often employed for endoscopic examinations in Germany and Switzerland than in the United States and the United Kingdom: in the USA and the UK patient sedation took place in up to 88 % of endoscopic examinations [1, 2] , whereas in Germany and Switzerland the figure was about 9 % [3, 4] . However, a recent "nationwide evaluation of sedation in gastrointestinal endoscopy in Germany" has shown a pronounced increase in the frequency of sedation for endoscopic intervention, which is now given in up to 88 % of cases [5] . This is most likely due to the increase in interventional procedures, and also to patient preferences, e. g., during colon carcinoma screening.
Apart from the long-familiar and most common form of sedation using sedatives such as benzodiazepines -sometimes in combination with opioids -the short-acting hypnotic propofol, with its plasma half-life of 7 -8 minutes, is increasingly coming into use. The advantage of propofol is that the recovery time is significantly shorter while patient tolerance is equal [6, 7] . In addition, the patient recovers psychomotor capacity much more quickly, as shown using a driving simulator [8] . However, now and again different sedation depths may be crossed with a single dose of this drug, which can cause sedation to be deeper than intended. Furthermore, unlike for midazolam, no antagonist exists for propofol. The recommendation of the various professional associations is still that the patient should not use the roads (even as a passenger) for 24 hours after the intervention [9 -11] . There is a lack of evidence to support this advice, and it may not reflect the more rapid recovery that is achieved after the administration of shorter-acting agents. A current issue of debate is propofol sedation by nurses ("nurseadministered propofol sedation" or NAPS). The increasing costs incurred under the Diagnosis-Related Group (DRG) settlement conditions and hence the requirement to reduce the costs of individual examinations have triggered a discussion of whether the sedation can be carried out by trained nurses. Currently more than 200 000 patients have undergone NAPS without the need for endotracheal intubation [12 -18] . However, these were mostly healthy patients undergoing diagnostic examinations, and the propofol dosages used were on the low side. Thus, uncritical acceptance of this concept is not recommended. On the contrary, in Germany we have yet to define conditions that would make this procedure safe for patients (e. g., appropriate training in sedation and emergency management). The S3 guideline "Sedation for Gastrointestinal Endoscopy" presented here by various medical professional associations (among them gastroenterologists, surgeons, and anesthetists) and patient self-help groups is intended to define the structural requirements needed for sedation in gastrointestinal endoscopy and the control of any sedation-related complications, including legal aspects.
The main rationale for the preparation of the guideline is the increasing role of sedation in gastrointestinal endoscopy. In addition to optimal patient preparation, which includes not only adequate information about the sedation, but also risk stratification of the individual patient, an overview will be given of the most common current sedatives and analgesics (with particular attention to the increasingly used short-acting substances) and their efficacy and side-effect profiles. Drug therapies with different substances will be compared in terms of their efficacy and effectiveness during the examination and their risk profiles (particularly in relation to individual risk groups). Patient preferences, quality management of sedation using appropriate monitoring, and incident management will be covered.
The goals of the S3 guideline "Sedation for Gastrointestinal Endoscopy" are defined as follows:
" To take account of recent advances in evidence-based medicine and recognized sedation and monitoring procedures in the implementation of the guideline.
" To compare drug therapies with various substances with respect to their efficacy and effectiveness and to their risk profiles (especially in relation to individual risk groups).
" To describe patient preferences, and to establish quality management of sedation with appropriate monitoring and incident management.
" To support doctors and patients in medical decision making with evidence-based and formal consensus recommendations.
" To support patient involvement in therapy decisions, taking their individual needs into account.
" To comprehensively implement multidisciplinary, quality-assured, and sector-spanning care of patients who need sedation during endoscopy.
" To support the documentation of complications arising during sedation.
" To systematically consider recommendations in training, further education, and continuing education, and in quality management systems.
" To create basic contents for targeted training, further education, and continuing education for physicians and healthcare staff.
" To systematically consider the recommendations and hence the quality indicators derived from them in external, comparative quality assurance and standardization of documentation standards.
" To comprehensively implement quality-assured patient care during sedation for gastrointestinal endoscopy.
" To optimize patient safety. The guideline is intended to complement and link up with the already existing recommendations on sedation for gastrointestinal endoscopy by nonanesthetists [9 -11, 19 -25] , and to the other projects and measures mentioned above, with the aim of improving patient safety in the medium and long term.
Organizational procedure and fundamental methodology of the consensus process (short version of the guideline report) The tasks of the steering committee included contacting and giving feedback to the professional associations and organizations involved, implementing methodological specifications for stage 3 guidelines using a project plan, administering the financial resources, supporting the work on content by the experts, consolidating and editing the text drafted by the experts of the working groups, and preparing the guideline methods report.
Selection criteria for the circle of experts, the working groups, and their tasks
The guideline group was convened by the coordinators. All professional associations, task forces, and organizations directly relating to the subject of the S3 guideline were contacted. They were asked to appoint experts as members who would represent them in the voting process (consensus process) and who would work on contents in the groups on specific topics (for members, see• " Table 1 and 2). All experts were chosen and invited according to their expertise and professional qualifications. The goal was to guarantee a multidisciplinarity and multiprofessionality within the guideline group that was appropriate for the guideline with respect to its content and application. A representative of self-help organizations was from the beginning actively integrated in the guideline preparation process in order to give stronger profile to the patients' perspective.
Systematic search for evidence
The literature search was carried out in a decentralized manner within the working groups with the support of the guideline coordination office. Search strategies for the preparation of the guideline were defined as follows:
" Databases: Pubmed, Cochrane Library " Search terms: -General: "sedation OR conscious sedation" and "endoscopy OR gastrointestinal endoscopy"
-Working-group-specific (• " Table 3 ) " Time period: 1990 -2007 In this way, 4079 publications were identified. After a preview by the heads of the working groups, 210 sources were chosen for evaluation. Publications not in English or German and ones with irrelevant content were not included. In addition, a manual search was done and relevant publications were added by members of the working groups. This led to the inclusion of 23 additional publications in the guideline. All sources were entered into a literature database by the guideline coordination office. Fortyfour publications were relevant for more than one topic and were separately evaluated with respect to each; some of these therefore have more than one entry in the evidence tables. In addition to the literature search, a targeted guideline search was done according to the following strategy:
" Databases: Pubmed and Guidelines International Network (GIN)
" Search terms: "sedation AND gastrointestinal endoscopy" " Time period: 1990 -2007 Eleven publications were identified in this way.
Section/topic complex Working group, spokespersons The evaluation of the relevant literature was done by members of the individual working groups (• " Table 4 .
The formal consensus procedure employed the techniques of the nominal group process, formal consensus conferences, and the Delphi technique. The voting process with all contributions of content as well as the voting results and evaluation of consensus strength were documented and rationales provided (• " Table 5 ).
Consensus procedure
During the first consensus process in January 2007 in Hannover, the methodological concept for the guideline preparation, the structure, and the key questions were determined. Subsequently, the working groups were appointed (see • " Table 2) . Furthermore, the guideline group was checked for completeness. The appointment of further experts or inclusion of other professional groups was not considered necessary by the guideline group. In a second consensus process, members of the working groups chose sources, formulated key statements and recommendations, demonstrated evidence levels on which they are based, and expressed recommendation grades based on primary literature. In the second formalized consensus process the suggested key statements and recommendations including the grading were discussed. The recommendation grades were then adjusted in the light of standard consensus criteria. Where evidence levels diverged from the recommendation grade, reasons were given. In addition to the recommendation grade, all key statements and recommendations are given as evidence level and consensus size. The process of reaching consensus was done at one 2-day and one 1-day structured consensus conferences of the entire guideline group, which took place in June and September 2007 in Hannover and Frankfurt am Main, respectively. The consensus conferences were structured in a series of steps: Part 1: Short presentations " Introduction to the methods of the formal consensus process by the presenter " Display of medical/scientific state of knowledge for each topic complex by the heads of the working groups " Opportunity to ask questions on the methodological procedure and on the rationale of the results in the plenary session Part 2: Structured consensus finding " Proceeding section by section, every key statement and every recommendation is called individually by the presenter " Registration of comments from the plenary session by the presenter " Clarification and rationale of alternative suggestions " Preliminary vote on initial draft and all alternatives " Determination of discussion points and differences of opinion " Debate and discussion " Final vote The key statements in Working Group II Pharmacology and Working Group IV Process Quality that were not put to vote at these meetings were voted on in a modified Delphi process. The addressees were all members of the guideline group. The following details were requested for each section of the guideline:
" Agreement " Disagreement " Concrete, well-argued proposals for modification, including references In the Delphi process all members of the guideline group were additionally asked to give quality goals which they thought were relevant. These goals were based on recommendations with high evidence levels [1, 2] . The results of the first survey (first Delphi round) were summarized and then presented to the guideline group. The sections on which there was no consensus and the suggestions for modifications were put to the vote again in July 2008 (second Delphi round). The final consensus of the complete guideline text was also done in writing in a modified Delphi process in August 2008. Finally, in September 2008 the complete guideline text was presented for acceptance to the executive committees and board of directors of the participating professional associations and organizations.
Circulation and implementation of the guideline
The S3 guideline "Sedation in Gastrointestinal Endoscopy" will be published in the following formats: 1. Short version in German and English (journals with peerreview process), short version of the patient information 2. Complete version (short, long, and patient version, and methods report) on the internet (www.awmf-leitlinien. 3. Complete version in English on the internet (Guidelines International Network, GIN: www.g-i-n.net) The S3 guideline will be published in electronic and printed form. It will be made freely accessible with the following elements via the internet portals of the AWMF (www.awmf-leitlinien.de, AWMF-register no. 021 / 014), the German Society for Digestive and Metabolic Diseases (www.dgvs.de, category "Leitlinien der DGVS"), and the German Society for Anesthesiology and Intensive Care Medicine (www.dgai.de):
" Long version: complete text, recommendations, and algorithms with detailed background information and short methods report on the rationale for the individual recommendations and comprehensive list of references " Short version as an appendix to the long version: summary of the health care recommendations including the evidence levels and the recommendation grades " Guideline methods report: detailed demonstration of the development process methodology The special formats are an integral part of the implementation strategy. Clinicians and others are explicitly encouraged to use the publications listed at 1 -3 above to support implementation of the guideline. This would include, for example:
" Implementation of the algorithms in hospitals and practices (clinical local treatment pathways, training, and corresponding local development of aids: e. g., pocket formats for lab coats; inclusion in supporting media: inclusion in hospital and private practice electronic information systems as part of quality management)
" Inclusion of the guideline in existing and planned training programs (e. g., simulation workshops on sedation analgesia and complication management)
" Implementation of patient information as part of public relations work: e. g., postcard formats, display on the internet, leaflets Circulation and implementation of the guideline will continue to be supported by the steering committee by:
" Public relations work by the committee that prepared the guideline:
-Press releases to the scientific information service idw (idw-online.de);
-Press conferences " Direct approach to the target users of the guideline:
-Contributions in professional journals and books -Conferences, presentations, seminars -Support in preparing materials for training and further education (CME-accrediting according to the state medical association)
Funding of the guideline and statement of possible conflict of interest
The preparation of the S3 guideline was supported by a grant of 30 000 euros from the DGVS. These funds were used for personnel costs (guideline office), costs for strategy meetings and consensus processes (traveling expenses for all participants, rent for meeting rooms, technical services, and catering), costs for office supplies, and fees for external experts consulted for methodological support. The guideline was produced independently of the funding organization. We thank the authors and participants in the consensus process for their entirely voluntary work. All members of the guideline group gave written statements on possible conflicts of interest, particularly with respect to commercial companies.
Period of validity and update procedure
The guideline is valid until December 2012 at the latest. A complete revision and new edition is planned at this time. The guideline groups will watch for new findings that may make the revision of individual sections or recommendations necessary, and the coordinator would be glad to receive relevant information in this regard from users of the guideline. The aim is produce continual updates as necessary. The date of the publication, the date of the next planned revision, and notification of planned and/or interim revised versions will be displayed in the publicly accessible directory of the AWMF ( http://www-awmf-leitlinien.de). The valid version with always be the most recent one according to the AWMF register. Comments: One randomized controlled study [27] and two prospective cohort studies [28, 29] underlie these recommendations. However, the rate of patient agreement to unsedated colonoscopy was only 88 % [28, 29] . In another study only 20 % of respondents agreed to colonoscopy without sedation. Male sex, higher education, and lower anxiety were positive predictive factors for a preference on the part of the patient for unsedated colonoscopy [30] .
Recommendation on indications for sedation
Recommendation: The following should be considered when deciding for or against sedation and/or analgesia:
Comments: Undoubtedly, premedication is not necessary for all endoscopic gastroenterological procedures. Ultimately it depends on the nature of the examination and its duration, complexity, and invasiveness. Premedication contributes greatly to the comfort of the examination for both patient and physician, and in some cases, especially complex therapeutic interventions, it may be what allows the intervention to be performed successfully and with low risk. Patient preference also plays an important role that should not be underestimated. Experiences of previous endoscopic examinations, anxiety, and the patient's understanding of the procedure all need to be taken into account. In addition, there are often cultural variations around the world with regard to sedation for gastrointestinal endoscopy. For example, in the United States and the United Kingdom, up to 88 % of endoscopic examinations are done under sedation [1, 2] . In contrast, in Germany and Switzerland the sedation frequency reported in the 1990s was much lower (about 9 %) [3, 4] , although it went up with the complexity of the examination. However, recent survey results show a pronounced increase in sedation frequency for endoscopic interventions in Germany (up to 87 %) [5] . This is probably due to the increase in interventional procedures and also to patient preference, e. g., during colorectal cancer screening. However, almost no studies exist that compare the safety of diagnostic and therapeutic endoscopy with to those without sedation (see Evidence• " Table 1 and 2 in the methods report). An American study failed to reach the intended comparison goal because of lack of patient acceptance (high preference for sedation) [27] .
The results of a German study showed that colonoscopy can be done without sedation in more than 90 % of cases with a low risk of complications [28] . However, in general the majority of patients prefer premedication [28, 31, 32] . Sedation does not seem greatly to influence the risk of the endoscopic procedure itself. A prospective study by Dillon et al. [33] of colonoscopy in 136 children under general anesthesia showed that the perforation rate was no higher than for adults under sedation. The claim that fewer perforations occur during colonoscopy if pain perception is maintained has therefore not been confirmed. Table 8 ) and the structure quality are the basis of the existing guidelines [9 -11, 19, 20, 36 -41] . Patients in ASA grade III or higher have an increased risk of complications due to sedation or the endoscopic intervention (• " Table 9). The upgrade of the abovementioned statement to a recommendation grade A when the evidence level is 5 is due to a 2b evidence level for ASA grade and co-morbidity and to patient safety considerations.
Recommendation
Recommendation on anesthesia/intubation
Recommendation: Calling in an anesthesiologist should be considered for patients with a high risk profile. This includes: high ASA grade (III -IV) and a difficult endoscopic intervention or the presence of pathological anatomical features associated with a higher risk of airway obstruction during the intervention (e. g., craniofacial malformation; lingual, laryngeal, or hypopharyngeal tumor; severely restricted mobility of the cervical spine; severely restricted mouth opening < 3 cm; Mallampati stage 3 or 4; or a restricted hyoid-to-chin distance < 4 cm).
Recommendation grade A, evidence level 5, consensus
Comments: The risk profile includes pathological/anatomical features that can lead to respiratory problems and could make support by mechanical ventilation or artificial respiration difficult. In addition, existing guidelines give recommendations on the assessment of increased risk of airways obstruction [9, 19, 35, 36, 42] in patients with previous problems related to anesthesia or sedation. These are: 1. Patients with stridor, snoring, sleep apnea. 2. Patients with malformation of the facial bones, e. g., PierreRobin syndrome or Down syndrome. 3. Patients with malformation of the mouth, such as small opening (< 3 cm for adults), agomphiasis, projecting anterior teeth, missing or broken teeth, strongly curved palate with macroglossia, tonsil hypertrophy, or a uvula that is not visible. 4. Patients with abnormalities of the neck, such as obesity involving the neck and face, short neck, restricted neck mobility, reduced hyoid-to-chin distance (< 4 cm for adults), neck tumors, disease or trauma of the cervical spine, tracheal alterations, or advanced rheumatoid arthritis. 5. Patients with jaw malformations such as micrognathia, retrognathia, the jaw typical of Down syndrome, or pronounced malocclusion. 6. Due to their risk profile, the requirements for sedation are also expected to be higher for persons with alcohol abuse, drug abuse, or on chronic medication, and also for patients with a high ASA grade and/or for persons that are not able to cooperate.
Recommendation on protective intubation
Recommendation: Deep sedation leads to impairment of the protective reflexes (pharyngeal reflex, cough reflex). This can promote aspiration. In special situations in emergency endoscopy where there is increased risk of aspiration under sedation (e. g., severe upper gastrointestinal bleeding), tracheal intubation should therefore be considered, however, it should be born in mind that prophylactic intubation may itself be associated with an increased risk of pneumonic infiltrates.
Recommendation grade B, evidence level 4, strong consensus
Comment: It is a basic fact that deep sedation leads to restriction of the protective reflexes. For this reason, if additional risk of aspiration is present (e. g., during emergency endoscopy for upper gastrointestinal bleeding), tracheal intubation in order to avoid aspiration seems sensible. However, because there are no highquality studies that prove that the advantages of this procedure outweigh the disadvantages, it is not possible to issue a general recommendation in this respect. In a retrospective case-control study by Koch et al. [43] of a total of 62 patients, 42 of whom underwent prophylactic endotracheal intubation before the start of endoscopy for variceal hemorrhage, pneumonic infiltrates were subsequently demonstrated in 17 % of the intubated patients. This was not the case in the nonintubated patients. In addition, overall mortality was higher in the group that underwent prophylactic intubation (21 % vs. 5 %).
In another retrospective case-control study by Rudolph et al. [44] including a total of 220 patients, no significant difference was seen in the frequency of pneumonic infiltrates and overall mortality between the intubated and nonintubated groups. However, deaths due to aspiration were higher among patients who did not undergo prophylactic intubation (2 % vs. 0 %, respectively). Because of lack of clarity in such retrospective analyses about how patients were allocated between the groups, and thus a possible bias (severely ill patients are more likely to undergo intubation), such studies are only of limited value.
Recommendation on patient positioning
Recommendation: Just as for general anesthesia during surgery, it is important to ensure that sedated patients are positioned correctly in order to avoid position-related damage.
Recommendation grade A, evidence level 5, strong consensus
Comments: On the whole, damage due to positioning is not a major issue in gastrointestinal endoscopy. Nevertheless, it should be avoided as a matter of principle. Especially when under mild se- Table 9 Characterization of ASA classification grades III -IV in relation to patient-specific risk factors.
Decompensated heart failure Coronary heart disease Heart valve disease/replacement
Liver and kidney failure Pulmonary disease
Coagulation disorders dation, patients can move involuntarily; they should therefore be appropriately secured. Damage due to positioning is most likely to occur in patients undergoing ERCP (prone or left-lateral position) or when they are being transferred from the examination table to the bed. There is no direct evidence on the subject of damage due to positioning in endoscopy; the recommendation is based on the joint recommendation of the Professional Association of German Anesthesiologists and the Professional Association of German Surgeons [45] .
2 Sedatives/analgesics/drugs acting on the autonomic nervous system/combination therapy/methods of administration ! 2.1 Acceptance by the patient and the endoscopist 2.
Patient acceptance/satisfaction
Recommendation: Sedation increases the patient's comfort and hence his or her acceptance of the endoscopic intervention. The ideal sedation seems to be one that leaves no memory of unpleasant sensations but at the same time has a short duration of action. Recommendation grade A, evidence level 1b, strong consensus Comments: Endoscopy under sedation is preferred by 40 % -60 % of patients [46] . Especially young, anxious female patients benefit from sedation [27, 47] . Patients want first and foremost complete freedom from pain, followed by the wish to wake up as soon as possible [48] . A study by Abraham et al. [49] showed that gastroscopies under sedation were followed by fewer repeat procedures and were better accepted by patients. The higher rate of patient acceptance owing to sedation during endoscopic examinations has also been demonstrated in other studies [50 -54] . However, when benzodiazepines are used for sedation during gastroscopy, patients may have discomfort (especially retching and gag reflex) that the endoscopist may not notice. In a study by Walmsley et al. [55] , the incidence of discomfort of this kind that remained unnoticed by the endoscopist was 12 %. In colonoscopy, too, "moderate" sedation using midazolam can sometimes allow the patient to feel pain [27] without the endoscopist's necessarily realizing this. In contrast, when propofol is used for sedation during esophagogastroduodenoscopy (EGD), colonoscopy, and ERCP, patient satisfaction is as good as or better than when midazolam is used (• " Table 10 ).
Endoscopist satisfaction
Recommendation: Sedation increases the practicability and the completeness of the examination and thus improves examiner satisfaction (especially in interventional endoscopy). Recommendation grade A, evidence level 1b, strong consensus Recommendation: In interventional endoscopy, propofol is superior to midazolam with respect to endoscopist satisfaction.
Recommendation grade B, evidence level 2b, strong consensus
Comments: Sedation using midazolam during EGD can lead to high acceptance by the patient [61] but to dissatisfaction on the part of the endoscopist [62] . By combining midazolam with opiates, endoscopist satisfaction can be improved. A randomized study by Laluna et al. [63] of 107 patients compared midazolam combined with placebo and midazolam combined with meperidine for EGD. Endoscopist satisfaction was significantly better with the combination regimen (P < 0.001), whereas little difference was seen in patient acceptance. A randomized study by Ng et al. [64] of 80 patients investigated patient tolerance and endoscopist satisfaction during patientcontrolled sedation with propofol or midazolam for colonoscopy. The use of propofol led to significantly higher endoscopist satisfaction (P = 0.01).
Especially for longer and more complex interventions [65] , deep sedation may be needed to help ensure that examinations can be done safely without unwanted and uncontrollable involuntary movement of the patient. Two randomized studies by Jung et al. [66] and Wehrmann et al. [67] that investigated sedation for ERCP using propofol or midazolam showed significantly higher endoscopist satisfaction with propofol. However, increasing the depth of sedation, achieved by raising the dose of the various substances, also increases the incidence of unexpected/unwanted side effects (see dose recommendations in the product information of the various manufacturers,
• " Table 11 , and Section 2.2.3.1). 
General
Propofol is a sedative without analgesic effect. The sedating effect of propofol is based on the accumulation of γ-aminobutyric acid (GABA) because of reduced dissociation of the GABA receptors.
The exact pharmacodynamic mechanisms of propofol are still not completely understood. Propofol is extremely lipophilic and develops its effect within 30 -45 seconds. The sedation effect lasts only 4 -8 minutes after administration because the drug is rapidly metabolized by the liver. These characteristics (quick onset of action with short effect duration) make it a suitable sedative for gastrointestinal endoscopy [6 -8, 59, 60, 68 -70] . The effect of propofol is individually variable depending on age [71, 72] , body weight, co-morbidity, or concomitant medication. Occasionally a single dose can take a patient right through several levels of sedation (• " Table 6 and 7) and trigger short-term apnea [73] . However, in contrast to midazolam, no antagonist exists for propofol, and therefore all endoscopy teams that use propofol for sedation have to be able to control apnea rapidly (see Section 4.4, "Management of sedation-related adverse events"). In addition to hypoxemia, typically hypotension can occur when propofol is used [12] (• " Table 11 , Section 2.2.3.1).
Rare occurrences are bacteremia due to improper drug storage (with consequent bacterial contamination), which can cause sepsis, and occasional cases of pancreatitis [74, 75] . A so-called propofol infusion syndrome (with rhabdomyolysis) has also been described, though so far it has only occurred with long-term administration (> 48 hours) at high doses (> 4 mg/kg per hour) [76] . Propofol is contraindicated in patients with a known allergy to albumin, soy protein, or sulfite. Propofol is initially given as bolus to induce sedation. To maintain sedation, it is then either given as repeated boli or continuously administered using a perfusor.
Methods of propofol administration
Alternative modes of administration to the intermittent bolus mode that is currently most often used in German endoscopy are perfusor administration (with an initial single bolus for initiation), so-called "target-controlled infusion" (TCI), patient-controlled sedation (PCS), and "computer-assisted personalized sedation" (CAPS). Intermittent bolus administration and perfusor administration are standard procedures, while the other methods are still experimental in nature, at least with respect to their use in endoscopy.
Intermittent propofol bolus administration
With the intermittent bolus administration method, sedation is induced with an intravenous bolus adjusted to the weight and, if necessary, the age and any co-morbidity of the patient (e. g., 40 mg at < 70 kg b. w. or 60 mg at ≥ 70 kg b. w.); thereafter, repeated boli of, e. g., 10 -20 mg according to patient need are given to maintain the desired depth of sedation. If necessary, a benzodiazepine and/or opiate can additionally be given to induce sedation (see Section 2.3, "Combination therapies"). The intermittent bolus administration method was used in almost all published studies on the sedation efficacy of propofol for endoscopic examinations/treatments compared to that of other drugs (e. g., midazolam), and is therefore currently the best documented and most often used form of administration in endoscopy.
Continuous propofol administration using perfusor systems
For this mode of administration, too, a bolus of propofol adjusted for body weight and, if necessary, age and co-morbidity is given to induce sedation (if necessary, in combination with other drugs). Sedation is then (usually) maintained by weight-adjusted continuous propofol infusion. Dosage is according to the desired depth of sedation and the individual patient's risk profile. Most systems allow additional propofol boli as needed. Special perfusor systems for anesthesia automatically calculate the maintenance dose of propofol 1 % or 2 % solution required for a specified BP, blood pressure; HR, heart rate; ns, not significant; **, significant (P < 0.01). † Propofol group n = 14, midazolam/pethidine (meperidine) group n = 15. ‡ In both groups n = 40.
sedation depth once various patient parameters have been entered (e. g., weight, height, age). Perfusor administration of propofol is currently the method most often used to maintain total intravenous anesthesia worldwide. However, so far there are few studies on its use in endoscopy [77] . So far as we know, no randomized comparison study between perfusor administration and intermittent bolus administration in endoscopy has been carried out. Recommendation: The intermittent bolus method of administration may currently be regarded as the standard procedure for the use of propofol in endoscopy. Propofol administration using a perfusor is well documented in anesthesiology and is considered standard for totally intravenous anesthesia. However, few published data exist regarding its use in endoscopy. Recommendation grade A, evidence level 2b, strong consensus
Patient-controlled sedation analgesia
Patient-controlled administration of drugs originated in pain therapy and is today standard in postoperative analgesia (e. g., in the concept of "fast-track surgery"). With the help of a programmable infusion pump, patients can intravenously administer to themselves a defined dose of a drug at the press of a button. To avoid overdose, a time-delay option can be applied for repeat doses (so-called lockout mechanism). PCS may be useful for endoscopic examinations where relatively short episodes of pain can be tolerated by the patient, such as is frequently the case during colonoscopy (e. g., sigma passage, flexure passage). Administration of short-acting drugs via these systems (e. g., the Graseby 3000 pump) is ideally suited to these cases. A combination of propofol with short-acting opiates (e. g. alfentanyl) is often used. In randomized studies the use of a PCS system (propofol plus alfentanyl) led to similar patient satisfaction as for midazolam and meperidine [78] and diazepam and meperidine (called pethidine in Germany) [56, 79] ; in two other studies, even, patient satisfaction was higher than for midazolam [64, 77] . However, in another randomized study a higher pain score was reported for PCS than for midazolam [78] . Nevertheless, fewer adverse events (oxygen undersaturation or fall in blood pressure) were observed with PCS using propofol than with diazepam [56, 79] . In two of these studies, 97 % and 78 % respectively of the patients who were sedated using the PCS method for colonoscopy said they would be willing if necessary to repeat sedation with the same procedure [80, 81] . Younger age, female sex, and low patient satisfaction were independent factors for refusal of the PCS procedure.
In a Swiss study of PCS, 35 % of all patients who were approached refused to take part in the study, either because they wanted complete unconsciousness or because they did not want to take responsibility for their own drug administration [13] . However, among those patients who did take part, it was observed that a significantly lower dose of propofol was used when PCS was employed than with intermittent bolus administration by a nurse (NAPS) during colonoscopy [13] . Recommendation: If propofol is used for colonoscopy, with or without opiates, patient-controlled sedation is an alternative to bolus administration. Recommendation grade 0, evidence level 2b, strong consensus
Target-controlled infusion
The target-controlled infusion (TCI) method allows intravenous administration of propofol (or other drugs) using an infusion pump. The dose and infusion rate are regulated by computer [82] . The computer system calculates the individual infusion rate from the pump needed to maintain a preset desired drug concentration in the blood, using algorithms that take account of various parameters relating to the patient (e. g., age, sex, height, weight, sedation depth). After the initial dose required to reach the desired blood concentration has been calculated, the infusion rate is adjusted during the course of sedation (the desired blood concentration is defined by the physician: this is the "open system").
With special systems the infusion rate can be varied on the basis of muscle tone, auditory evoked potentials, and/or other physiological parameters that reflect the depth of sedation, thus allowing regulation of the sedation ("closed systems").
The potential advantage of the TCI method compared to continuous infusion (with fixed dose and infusion rate) is the ability to avoid accumulation of the drug, since the infusion rate is constantly being changed.
In an evaluation by Fanti et al. [83] of 205 patients who underwent ERCP under deep sedation (without assisted ventilation), an open TCI system with propofol was used. The initial desired concentration was 4 µg/ml, followed by maintenance by the anesthesiologist in the range 2 -5 µg/ml during the course of the procedure. In addition, a bolus administration of fentanyl (50 -100 µg i. v.) was allowed. The endoscopists rated the sedation as excellent in 201 of 205 cases; only four cases of hypoxemia (PO 2 < 85 %) were observed, and one case where ventilation with a mask was necessary. In another trial, colonoscopy was performed in 16 patients using a closed TCI system where the infusion rate was controlled by means of EEG (bispectral index determination) [84] . In this study by Leslie et al. [84] , a median propofol concentration of 2.3 µg/ml was aimed at; predominantly, a bispectral index of 80 was seen (corresponding to a mild to moderate depth of sedation).
Further studies investigated the combined use of TCI and PCS, in which the patient was able to modify the administration rate of the TCI pump by pushing a button. Positive sedation effects were reported during colonoscopy and ERCP [84 -87] . However, the case numbers were small (n = 20 -40). In a randomized study by Stonell et al. [87] that compared the TCI/PCS system to repetitive bolus administration of propofol by an anesthesiologist during colonoscopy (n = 40), no significant differences were found in sedation efficacy or complication rate. The total propofol dose tended to be lower in the TCI group than in the bolus group (233 vs. 288 mg, P = 0.05).
Computer-assisted personalized sedation
The computer-assisted method of personalized sedation (CAPS) extends the TCI dosing of propofol by the addition of various monitoring parameters, both physiological (pulse frequency, blood pressure, O 2 -saturation, and exhaled CO 2 ) and in the form of patient reactions to specific verbal (via headphones) and tactile stimuli (via a vibration mouse). Sedation is thus implemented and monitored entirely by computer. Currently, this system only allows the regulation of moderate sedation depths: deep sedation and anesthesia are not yet envisaged. This system is not currently licensed for clinical use in Europe.
In an initial two-center evaluation in the US and Belgium, an adequate sedation effect without complications was observed in a total of 96 patients undergoing gastroscopy or colonoscopy. Following an initial bolus administration of fentanyl (25 -100 µg), between 20 mg and 350 mg (median 70 mg) propofol was administered via this system [88] .
Recommendation: TCI and CAPS have been investigated in several studies. No recommendation can be made on the value of these procedures on the basis of the data currently available. Recommendation grade 0, evidence level 1b, strong consensus
Benzodiazepines
Benzodiazepines induce anxiolysis, amnesia, and sedation, and have both anticonvulsant and muscle-relaxing effects. They act by binding to the GABA A receptor. Different benzodiazepines can have different pharmacologic characteristics (e. g., a stronger sedating effect or a stronger anxiolytic effect) [89] .
Diazepam
Diazepam was the only available sedative when endoscopy started, but is now rarely used in the western world for endoscopic examinations. This is because it has a relatively long half-life compared to more recent short-acting benzodiazepines such as midazolam [90 -92] . The main side effects of diazepam are respiratory depression [93] , coughing, and dyspnea. Phlebitis can occur at the injection site, especially if water-soluble forms are used [94] . The usual dose is a single injection of 5 -10 mg (see also dose recommendation in the manufacturer's product information).
Midazolam
Midazolam is a short-acting benzodiazepine that is still the most commonly used sedative for endoscopy [95] , with a sedation potency 1.5 -3.5 greater than that of diazepam [96] . It is effective after 1 -3 minutes and reaches maximum effect after 3 -4 minutes, although the duration of effect is between 15 and 80 minutes [97] depending on cofactors such as obesity, advanced age, and liver and kidney disease. The side-effect profile corresponds to that of diazepam but phlebitis is less common [98] . As sometimes also occurs with other benzodiazepines, midazolam administration can in rare cases lead to paradoxical reactions characterized by aggressiveness, hostility, and agitation. This phenomenon has been described in about 5 % of patients receiving midazolam by short-lasting oral administration [99] . A study by Christe et al. [100] on sedation with midazolam of older patients (mean age 84 ± 7 years) undergoing EGD showed confusion in 14 % of them even on the next day.
Midazolam is usually given as a bolus of 30 -80 µg/kg body weight for gastroscopy [6, 7, 100, 101] . For colonoscopy an initial bolus between 30 and 50 µg/kg is usually given. Subsequently, lower-dose boli are given until the desired sedation depth is reached [64, 102, 103] . The use of lower doses is recommended for patients older than 60 years [79, 100, 103 -105] . If sedation is the patient's preference, it is generally better to administer midazolam before the start of the examination rather than during it according to need [106, 107] .
Antagonistic effect of flumazenil on midazolam
The effect of midazolam can be inhibited by using the benzodiazepine-specific antagonist flumazenil [108, 109] . A study by Mora et al. [110] showed that flumazenil has a stronger antagonistic effect on benzodiazepine-induced sedation and amnesia than on respiratory depression. Neutralization of the midazolam-induced respiratory depression occurs 120 seconds after intravenous flumazenil administration [111] . The half-life of flumazenil is 0.7 -1.3 hours, and the average duration of the antagonizing effect is 1 hour. Since the effect of midazolam can last 80 minutes or longer, there is a danger of resedation, necessitating further administrations of flumazenil.
In a study by Andrews et al. [112] Comments: Amnesia following the use of midazolam has been well studied [123] and in all studies has been shown to be significant. If amnesia is not desired, midazolam should not be used. An alternative benzodiazepine is diazepam [91, 92] . The longer half-life of diazepam has not been reported in studies as a disadvantage compared to midazolam [92, 96, 124] . However, in some studies patient comfort was lower after diazepam than after midazolam. With respect to amnesia midazolam has the highest potency of all sedation methods.
Propofol versus midazolam
Recommendations: Data on efficacy, recovery, and complications suggest that propofol should be preferred to midazolam for sedation during gastrointestinal endoscopy. However, adjustments still need to be made taking into account the individual patient situation, the nature of the intervention, and the personal, personnel, equipment, and structural requirements indicated in this guideline.
Recommendation grade A, evidence level 2b, strong consensus
Comments: A summary of the existing randomized studies (• " Table 10 , Section 2.1.1) of patient acceptance or satisfaction shows that endoscopists judge propofol to be as good as benzodiazepines for sedation [56 -58] , or better [59, 60] . Randomized studies suggest that propofol is preferable for EGD, colonoscopy, and ERCP [6 -8, 58 -60, 66 -70, 115] . The advantage of propofol sedation compared to benzodiazepines, for both the patient and the endoscopist, is a shorter time of onset [59] , significantly better patient cooperation [66, 67, 115 ] -especially in interventional endoscopy (such as ERCP) -and a shorter time for recovery [6 -8, 58 -60, 66 -70] , including recovery of psychomotor function [8] .
Two studies showed the superiority of propofol compared to midazolam/fentanyl with respect to recovery of neuropsychological/cognitive functions after ambulatory colonoscopy [57, 58] . A randomized study by Riphaus et al. [8] on recovery of psychomotor function (assessed using a driving simulator) after sedation with propofol versus midazolam/pethidine (comparable with meperidine, mostly used in the United States and the United Kingdom) for EGD or colonoscopy also reported a significantly faster recovery time and quicker recovery of psychomotor function with propofol. Another advantage of propofol compared to midazolam is the possibility of better-quality examinations. This was addressed in a study by Meining et al. [116] that compared propofol and midazolam sedation for EGD. The study showed that the quality of the depiction of the upper gastrointestinal tract (on video) was improved when patients were sedated with propofol. However, the endoscopic examination time was longer in the propofol than in the midazolam group [116] . Sedation with propofol makes colonoscopy examinations easier [117] ; moderate sedation ("conscious sedation") is usually sufficient [118] .
Cardiorespiratory complications
Comparative data on complications from 12 randomized studies were compiled in a meta-analysis by Qadeer et al. [119] that described the relative risk of sedation with propofol compared to benzodiazepines. The use of propofol for colonoscopy was associated with significantly fewer side effects. For other endoscopic interventions (EGD, ERCP) no significant difference was seen. When propofol is used for ERCP there is in some cases a significantly higher risk of arterial hypotension compared to midazolam/pethidine or meperidine [58, 66, 115, 120, 121] . There is also a tendency for oxygen saturation to drop below 90 % with propofol sedation, although this is not statistically significant (see• " Table 11 ). In a recently published risk factor analysis by Wehrmann and Riphaus [122] in 9547 patients who received propofol sedation for interventional upper endoscopy over a period of 6 years (EGD, n = 5374, ERCP, n = 3937, EUS, n = 236), 3151 patients had monosedation with propofol and 6396 patients sedation with a combination of propofol and midazolam. A total of 135 severe complications were reported (1.4 %), leading to discontinuation of the intervention. Short-term mask ventilation was necessary in 40 patients (0.4 %) and endotracheal intubation in 9 patients (0.09 %). Eight patients needed additional observation in the intensive care unit (0.3 %) and four patients died, three of whom had side effects that could have been sedation-related (mortality rate 0.03 %). After multivariate analysis of the data, emergency interventions and a higher propofol dose were assessed as independent risk factors for cardiorespiratory complications [122] .
Other drugs as monotherapeutics
Introduction
Other drugs are additional either sedating/hypnotic or analgesically active substances that do not fall into the usual substance classes. These include opiates and ketamine (as monotherapeutics), inhalation anesthetics, nonsteroidal anti-inflammatory drugs (NSAIDs) and neuroleptanalgesics. The few studies from the past that exist on these substances show at a moderate level of evidence that these drugs are in principle suitable for sedation. Evaluating the existing literature, the following points stand out:
1. 
.1 General
Fentanyl is a lipophilic synthetic morphine derivative that is chemically related to pethidine. It is about 600 times more potent than pethidine and 100 times more potent than morphine. The effect starts only about 20 seconds after intravenous administration as the substance binds to specific opioid receptors in the brain and spinal cord. The maximum effect is expected after 6 minutes and the duration of effect is 20 -30 minutes. The initial dose is usually 50 -100 µg. In older patients the dose should be reduced. The most common adverse side effect is respiratory depression, which because of the strong potency of the drug may be expected with a dose of as little as 0.1 mg (for adults). In addition, thorax rigidity can occur, which can make it more difficult to ventilate the patient should that prove necessary. The effects on blood pressure and heart rate are fairly mild, usually causing a drop in these parameters due to vagal stimulation. Spasming of the smooth muscles of the bile duct and pancreas and spastic constipation can also occur. Nausea and vomiting under fentanyl is comparable to other opiates. Although fentanyl is usually used for general anesthesia (often in combination with other drugs) or for chronic pain (usually transdermally), there are few studies with small patient numbers on its use as an analgesic for endoscopy. Comments: A prospective study on flexible sigmoidoscopy by Basu et al. [125] investigated 109 consecutive patients who received analgesia with a single bolus of fentanyl (50 µg) or no analgesia, according to patient preference. Significantly fewer of the 46 patients who received analgesia complained about moderate or severe pain than of the 63 who had no analgesia (9 vs. 26, P < 0.05). Patient satisfaction, especially with regard to repeat examinations using the same procedure, was significantly higher with analgesia than without (P < 0.01). An increase in cardiorespiratory complications with fentanyl was not reported.
Another randomized study by Ishido et al. [126] of 84 patients undergoing EGD either under fentanyl sedation or without sedation showed that in addition to increasing patient tolerance analgesia also reduced the increase in heart rate induced by endoscopy. Apart from a minimal decrease in arterial oxygen content there was no significant difference in O 2 saturation between the two groups.
Remifentanil 2.2.4.2.2.1 General
Currently, data on the routine use of remifentanil, a highly potent synthetically synthesized opioid with an extremely short half-life (2 -3 min), are sparse. Notable points are an increased incidence of respiratory depression and that the drug should only be used as a continuous infusion for analgesia in spontaneously breathing patients. Its use is restricted to facilities that are completely equipped for monitoring and support of respiratory and cardiovascular functions (according to product information).
Comments: In a randomized study by Akcaboy et al. [127] 100 patients received a continuous infusion of remifentanil (bolus 0.5 µg/kg, then 0.05 µg/kg per minute continuously) or propofol (bolus 0.5 mg/kg, followed by 50 µg/kg per minute) for colonoscopy. The duration of the examination was longer and the oxygen saturation after bolus administration was lower after remifentanil than after propofol. Although the recovery time was shorter for remifentanil, the time to hospital discharge was comparable. Nausea and vomiting were observed much more frequently in the remifentanil group.
Ketamines as monotherapeutics 2.2.4.3.1 General
Ketamine is an intravenously or intramuscularly injectable general anesthetic with strong analgesic effect. It is mainly used as a "monoanesthetic" for short diagnostic and therapeutic interventions in children and for special situations in adults. After intravenous bolus administration ketamine has a rapid onset of action (< 1 min) and an effect duration of about 10 -15 minutes [128] . It causes so-called dissociative anesthesia that is probably elicited by functional decoupling of the thalamoneocortical system from the limbic system. The analgesic effect starts at sub-dissociative doses and lasts longer than the anesthesia. The sedative and hypnotic properties of ketamine, however, are much less pronounced. Muscle tone is maintained or increased under ketamine anesthesia so the protective reflexes are not affected. The spasm threshold is not reduced. With spontaneous breathing, intracranial pressure rises. Because of its sympathicotonic effect, ketamine leads to a rise in blood pressure and heart rate, which in turn causes an increase in myocardial oxygen consumption and concomitantly increased coronary perfusion. Ketamine displays a negative inotropic and antiarrhythmic effect on the heart itself. As a result of the opposing influences, the peripheral resistance barely changes. Moderate hyperventilation is observed after ketamine administration. It has a relaxing effect on the bronchial muscles. Contraindications for the use of ketamine include insufficiently treated or untreated arterial hypertension (systolic/ diastolic blood pressure above 180/100 mmHg at rest) and patients for whom a rise in blood pressure would constitute a substantial risk (e. g., history of cerebrovascular insult). Relative contraindications include unstable angina pectoris or myocardial infarction in the preceding 6 months. Since in general the pharyngeal reflexes are maintained, mechanical irritation of the pharynx should be avoided when ketamine is employed as a monoanesthetic unless additional muscle relaxants are used. For interventions in the pharynx, larynx, and bronchial tree especially, therefore, muscle relaxation with ventilation may be necessary. One adverse side effect is the frequent occurrence of hallucinations, nightmares, and delirious states in about 10 % -30 % of cases. These reactions can be reduced by giving midazolam in addition [129] . Comments: For the reasons given above, ketamine is not recommended as a routine monotherapeutic for endoscopic examinations. Most studies on the use of ketamine relate to its use in combination therapies -mainly with midazolam -for endoscopic interventions in children [130, 131] . It was shown that adequate sedation can be achieved without cardiorespiratory complications.
Although the data on the use of ketamine in adults are limited, there are indications that adjunctive use of ketamine, in combination with midazolam, can be beneficial for certain patients (all contraindications being observed). A double-blind, placebo-controlled study by Rosing et al. [132] that compared midazolam/ placebo with midazolam/ketamine for colonoscopy in 129 patients showed that patients receiving the combination therapy needed fewer repeat injections (40 % vs. 27 %), had better sedation and analgesia, and were more willing to agree to undergo another similar procedure. A randomized study by Ong et al. [133] that compared ketamine combination sedation (ketamine plus midazolam, pentazocine, propofol) with propofol monosedation for ERCP demonstrated that especially in younger patients the benefit of the combination sedation was better patient tolerance. However, patient satisfaction was similar in both groups. In addition, hypoxia occurred more frequently when the combination therapy was used.
Inhalation anesthetics as monotherapeutics 2.2.4.4.1 Dinitrogen monoxide (nitrous oxide, laughing gas)
General
Nitrous oxide (N 2 O), so-called "laughing gas," is a stable, slow-reacting, colorless, and odorless gas. It is strongly analgesic and mildly narcotic. Voluntary movement is not influenced. Its advantage is its rapid onset of effect and short recovery time. Mixed with oxygen, it is normally used to initiate anesthesia, for combination anesthesia, or for analgesia for women giving birth in hospital. Nitrous oxide is inhaled. It must always be administered after vaporization (transition to gas phase) using suitable inhalation or anesthesia equipment. Although it normally affects the circulation only slightly, a drop in blood pressure, decreased stroke volume, and increased pulmonary vascular resistance can occur, as can dilatation of the cerebral vessels followed by a rise in intracranial pressure. Possible adverse side effects are nausea and vomiting. The occurrence of euphoria, dreams, and fantasies has been described. If the dose is too high, hypoxia, circulatory depression, agitation, or somnolence and even unconsciousness may occur. Comments: A randomized study by Saunders et al. [134] comparing patient-controlled nitrous oxide inhalation with intravenous midazolam/pethidine administration for colonoscopy showed that in addition to a significantly faster recovery time after nitrous oxide inhalation (32 vs. 60 min, P = 0.01), the drop in blood pressure and oxygen saturation was also smaller. However, headache often occurred with nitrous oxide inhalation. In another study by Forbes et al. [135] patients undergoing colonoscopy randomly received either nitrous oxide or midazolam/ meperidine (average dose: 4.7 mg and 55 mg). Nitrous oxide was less effective, patients more frequently recalled pain during the examination (P < 0.001), and were significantly less satisfied with the intervention (P < 0.01). However, the recovery time was significantly shorter than with midazolam/meperidine (30 vs. 60 min, P = 0.0001). In a study by Maleskar et al. [136] that was recently published as an abstract, 100 patients randomly received either nitrous oxide or midazolam/fentanyl for colonoscopy. In contrast to the study by Forbes et al., patient satisfaction was better under nitrous oxide, the patients reported less pain, and the time to hospital discharge was significantly shorter (26 vs. 44 min, P = 0.004).
Nonsteroidal anti-inflammatory drugs 2.2.4.5.1 Ketorolac trometamol 2.2.4.5.1.1 General
Ketorolac trometamol is a NSAID with analgesic effect and rapid onset of action within minutes after intravenous injection. Its mechanism of action is based on inhibition of prostaglandin biosynthesis. It is usually used for the treatment of acute pain. In Germany the substance is only available for administration as eye drops. Like other NSAIDs, ketorolac trometamol can cause gastrointestinal irritation, ulcers, bleeding, or perforation with or without preceding symptoms, and for this reason it should not be given to patients with known diseases of the gastrointestinal tract.
Other adverse side effects are fluid retention and edema, so care should be taken with patients with cardiac decompensation and hypertension. Headache, numbness, drowsiness, sweating, and dizziness also often occur. Comments: A randomized, double-blind, placebo-controlled study by Mui et al. [137] investigated the effect of intravenously administered ketorolac trometamol (60 mg) as premedication 30 minutes before the start of patient-controlled sedation (with propofol/alfentanil) for colonoscopy in a total of 140 patients. The pain scores as rated by both patients and endoscopists were significantly lower in the ketorolac group than in the control group (3.99 vs. 5.28, P = 0.006 and 80.0 vs. 57.1 %, P = 0.004). There were no significant differences between the two groups with respect to drug dose, patient satisfaction, and hemodynamic changes. Further data that demonstrate actual superiority of NSAIDs over the current usual sedation regimens are lacking and therefore no overall recommendation can be made for the routine use of NSAIDs.
Combination therapies 2.3.1 General
Combination therapies are usually comprised of a sedative and an analgesic or a combination of different sedatives. While monosedation with benzodiazepines such as diazepam or midazolam [138 -141] reduces stress-induced cardiovascular complications (e. g., myocardial ischemia, rise in rate-pressure product), combination with an opiate [142 -144] or hypnotic such as propofol [70, 145] also leads to increased patient acceptance. By combining different substances, the required dose can be reduced [146] and the recovery time shortened [59, 57, 143, 146] . However, it should also be remembered that, compared to monotherapy, combination therapy can often lead to a fall in blood pressure and oxygen saturation [147 -149] (see also Section 2.3.3). Another randomized, double-blind study by Radaelli et al. [144] that compared midazolam to midazolam/meperidine for colonoscopy in 253 patients reported significantly less pain and a higher rate of willingness to repeat the intervention under combination therapy. The recovery time and the fall in oxygen saturation were comparable in both study groups.
Specific combinations
In a randomized, controlled study by VanNatta et al. [150] 200 patients undergoing colonoscopy were given propofol alone to reach deep sedation or a combination treatment with propofol/ fentanyl, propofol/midazolam, or propofol/midazolam/fentanyl to reach moderate sedation. Recovery time, patient satisfaction, and vital signs were compared. Patients with propofol sedation alone needed significantly higher doses and showed deeper sedation stages than those given the other combination treatments (p < 0.001). The time to discharge was significantly shorter after the combination treatments than after propofol alone (median 13.0 -14.7 min versus 18.1 min, P < 0.01). Vital signs and patient satisfaction were comparable in all study groups.
Combination of sedative plus propofol
Recommendation: Combination with various sedatives (e. g., midazolam plus propofol) leads to the same acceptance/tolerance for the procedure with probably the need for a lower dose of propofol. Combination therapy with midazolam/propofol can be a good choice so long as the relevant structural and personal requirements are met.
Recommendation grade B, evidence level 1b, strong consensus
Comment: A study by Cordruwisch et al. [151] of 64 patients undergoing two consecutive, long (> 30 min) endoscopic examinations, who initially received propofol and then a combination of midazolam and propofol, showed that the advantage of the combination sedation was the significantly lower propofol dose required (reported as 59 % compared to monotherapy). However, the postinterventional recovery time was twice as long for the combination regimen (4 vs. 8 min). A study by Seifert et al. [146] of 239 consecutive patients undergoing therapeutic endoscopy (EGD and endoscopic ultrasonography) also demonstrated that the combination of propofol and midazolam led to a lower dose of propofol compared to monotherapy (0.20 ± 0.09 mg/min per kilogram body weight vs. 0.25 ± 0.13 mg/min per kilogram, respectively, P < 0.01), with otherwise comparable effectivity. However, the combination regimen was also associated with a longer recovery time (25 ± 8 min vs. 19 ± 7 min, P < 0.05). Similar dose reduction with the combination of propofol and midazolam was reported in the abovementioned study by VanNatta et al. [150] . However, the postinterven-tional recovery times were shorter in the combination therapy arm (13.0 -14.7 min vs. 18.1 min, P < 0.01) than with propofol monotherapy.
Combination of sedative plus spasmolytic Recommendation:
The combination of spasmolytics with sedatives increases the rate of cardiovascular side effects and reduces both patient satisfaction and the endoscopist's evaluation of the examination. The use of spasmolytics in sedation for endoscopy should therefore be carefully considered. Recommendation grade A, evidence level 1b, strong consensus Comment: A prospective, double-blind, placebo-controlled study by Mui et al. [152] investigated the use of the spasmolytic hyoscine N-butylbromide (Buscopan) for premedication in patientcontrolled sedation with propofol/alfentanil for colonoscopy. The study demonstrated a longer cecum intubation time, significantly lower endoscopist satisfaction, a significantly higher dose of sedative/analgesic, and significant hemodynamic instability.
Side effects of combination therapy
General
Even if the recommended dose reduction for combination therapy is followed, respiratory function is compromised more frequently than under monotherapy [147 -149] . Based on the existing studies it cannot be shown whether life-threatening situations occur more often under combination therapy. Comments: Rembacken et al. [149] investigated the role of pethidine for colonoscopy. In this randomized, double-blind, placebocontrolled study, 71 patients were sedated with diazepam or diazepam plus pethidine. Patient satisfaction was similar in both groups, but the endoscopists preferred the combination therapy because of better patient tolerance. However, with combination therapy oxygen saturation dropped twice as often as with diazepam monotherapy (P = 0.008). In another study by DiPalma et al. [147] on the role of alfentanil for colonoscopy, 35 patients randomly received either a combination of alfentanil/midazolam or midazolam alone. A fall in oxygen saturation resulting in a need for oxygen administration occurred more frequently than with the monotherapy. Patient tolerance, patient satisfaction, recovery time, and blood pressure were comparable in both groups. A randomized, double-blind study by Moerman et al. [148] investigated the addition of remifentanil to sedation with propofol in 50 relatively healthy patients (ASA grades I and II) undergoing colonoscopy. Blood pressure and oxygen saturation dropped significantly more often in the remifentanil/propofol group. Although the addition of remifentanil allowed the dose of propofol to be reduced, recovery time was significantly shorter (P < 0.01) and patientsatisfactionsignificantlyhigher(P < 0.01)withpropofolalone.
Monitoring/structure quality
Recommendation: Because of drug interactions, the dose of the drug in use should be adjusted in combination therapies. In addition, as the risk is difficult to calculate, care must be taken that adequate monitoring is available and that another physician experienced in cardiopulmonary resuscitation and ventilation (including intubation and assisted ventilation) can be called on to intervene immediately if required (also see Section 3). Recommendation grade A, evidence level 1b, consensus
Effect of co-morbidity 2.4.1 General
Co-morbidity basically means a higher ASA classification and concomitant diseases (including ASA grades II and III) that are associated with a higher incidence of side effects [71, 153, 154] . Older patients and patients with pre-existing coronary or pulmonary diseases in particular are at higher risk of complications during endoscopy with sedation [71, 138, 155] . Hepatobiliary diseases in which drug elimination is reduced, or age-related slower metabolism, can also lead to potentiation of side effects [156, 157] . A multiplicity of physiological processes contribute to increased sensitivity towards the various drug substances, leading to a correspondingly increased sedation risk [158] . With advancing age arterial oxygen saturation declines, with or without additional oxygen administration. The cardiorespiratory reaction to hypoxemia or hypercapnia is also reduced and delayed. Narcotics and other centrally acting substances lead to increased respiratory depression and more frequent occurrence of transient apnea.
Age-related diseases and rapid or excessive doses contribute more strongly to such cardiorespiratory complications than age per se [158] .
High-risk patients
Recommendation: Patients with a higher ASA grade and/or older patients are at higher risk of sedation-related side effects (cardiorespiratory depression). The dose of the sedative used should be adjusted accordingly. Recommendation grade B, evidence level 2b, strong consensus
Substance type
Recommendation: Sedation using propofol as a substitute for benzodiazepines can be considered for older patients and patients with cardiorespiratory or liver disease. Theoretically, a transient exacerbation of, e. g., hepatic encephalopathy, which has been demonstrated for benzodiazepines, is not expected to occur with propofol.
Recommendation grade 0, evidence level 2b, consensus
Comments: In accordance with the modified recommendations of the American Society of Gastroenterology for older patients undergoing gastrointestinal endoscopy [159] , fewer substances given more slowly and at a lower cumulative dose should be administered [159, 160] . Like young patients, older patients are usually sedated with midazolam and/or other opioids or narcotics. Since benzodiazepines increase the risk of hypoxemia in older patients, overweight patients, and anemic patients, a dose reduction is also recommended here [161] . This group of substances also carries a higher risk of postinterventional hypoxemia, especially in older patients [121, 162] . In addition, in patients with liver cirrhosis benzodiazepines lead to transient exacerbation of hepatic encephalopathy [156, 157, 163, 164] , which has not been seen with propofol monotherapy [164] . In a randomized study by Riphaus et al. [164] , 60 patients with known liver cirrhosis and portal hypertension were sedated in a ratio of 2 : 1 in a randomized fashion with either propofol or midazolam for gastroscopy with interventional intent (variceal ligation). Before and 2 hours after the examination all patients took a number connection test (ZVT-A) and a portosystemic encephalopathy syndrome test (PSE), the latter made up of four additional individual test components. The evaluation was based on an overall score from these tests. Twenty patients without liver cir-rhosis who did not undergo gastroscopy were the control group. Recovery time and the recovery score were also determined. Compared to sedation with midazolam, patients sedated with propofol had a significantly shorter recovery time (18.4 ± 6.7 min vs. 7.8 ± 2.9 min, respectively). Propofol also affected the PSE score less than midazolam, the use of which led to transient exacerbation of the existing subclinical hepatic encephalopathy. Hence, sedation with propofol tends not to cause exacerbation of subclinical hepatic encephalopathy in patients with liver cirrhosis and is therefore an alternative sedative for use in these patients. Since propofol has a limited therapeutic range, it can lead to more cardiorespiratory complications in older high-risk patients than in younger patients [71, 165] . Low initial doses of propofol (in general half the recommended dose for adults), slow, gradual titration, and careful monitoring are recommended for sedation of older patients [166, 167] . It has been shown that, used with due care, propofol can be safely employed for sedation in this age group [121, 165] . A cohort study by Vargo et al. [153] studied risk factors for cardiopulmonary events during propofol sedation for upper and lower intestinoscopy. The overall risk of a cardiopulmonary event during 528 gastroscopies and 1683 colonoscopies was 11.7 per 1000 cases. A higher risk was found in patients with increasing ASA grade who were undergoing colonoscopy. A study by Heuss et al. [165] on the safety of propofol sedation during endoscopic examinations (gastroscopy and colonoscopy) in high-risk patients (ASA grades III and IV) compared to patients in ASA grades I and II also showed that the high-risk group were at higher risk of a short-term but relevant drop in oxygen saturation below 90 % (3.6 % vs. 1.7 % for ASA grades I and II, P = 0.036). Short-term mask ventilation was necessary in four cases (ASA grades III and IV) compared to one case (ASA grades I and II). The dose required for adequate sedation in high-risk patients was 10 % -20 % lower than that required for patients classified as ASA grades I and II. Accordingly, the authors stipulated particularly careful monitoring in older high-risk patients. In a randomized, controlled study by Riphaus et al. [121] 150 patients over the age of 80 years were sedated with either propofol or midazolam and pethidine before undergoing ERCP. Clinically relevant cardiorespiratory changes were not observed more frequently under propofol than under midazolam/pethidine. The recovery time was significantly shorter with propofol (22 ± 7 min vs. 31 ± 8 min for midazolam/pethidine, P < 0.01). Furthermore, a drop in oxygen saturation below 90 % occurred significantly less frequently during postinterventional monitoring (12 % vs. 26 % for midazolam/pethidine, P < 0.01). It must be remembered that certain personnel requirements obtain (see Section 3.3) in respect of multimorbid patients and patients with an increased risk profile.
Music during endoscopy
Recommendation: The use of relaxing music has a positive effect on patient acceptance of colonoscopy and results in a reduction of the average dose of propofol or midazolam.
Recommendation grade B, evidence level 2b, strong consensus
Comment: A prospective randomized study by Harikumar et al. [166] investigated the effect of relaxing music on the dose of patient-controlled sedation with propofol in patients undergoing colonoscopy. Music significantly reduced the dose of propofol and midazolam and improved patient acceptance.
A recent meta-analysis by Rudin et al. [167] evaluated six randomized controlled studies with a total of 641 patients. In three studies endoscopy was done with music alone. This reduced the patients' fear in comparison to the control group by 8.6 % (P = 0.004). In the remaining three studies patients received music therapy in addition to drug therapy (midazolam, pethidine, or propofol/alfentanil). This significantly reduced the need for analgesics by 29.7 % (P = 0.001) and the need for sedatives by 15 % (P = 0.055).
Introduction
The endoscopic examination and/or treatment and the sedation procedure are distinct medical interventions. If one physician performs the diagnostic or therapeutic intervention and at the same time also carries out the sedation, he or she takes on full responsibility not just for the intervention but also for the sedation and/or analgesia, including monitoring and, if required, restoration of vital functions. Special theoretical and practical knowledge of sedation and/or analgesia is necessary not just for physicians, but also for supporting nurses. A physician cannot perform the invasive intervention and at the same time be monitoring the sedation and/or analgesia procedures. A specially trained person (usually a physician) other than the physician performing the intervention should be responsible for the sedation procedure and the monitoring of vital functions. The person who is monitoring sedation should not have any other duties at this time. The decision -and the responsibility for the decision -as to whether in certain cases (e.g. deep sedation or general anesthesia induced by propofol or combination therapies) this person can be not a physician but another qualified, specially trained person (a nurse), lies with the physician doing the diagnostic or therapeutic intervention, and must take into account the structure of the workplace, the patient's condition, and the complexity of the intervention. The examining physician (endoscopist) must ensure that such nurses are sufficiently qualified and capable of carrying out their tasks appropriately. The problem of organization/transfer of liability rests on general legal principles based on civil, criminal, and occupational law. The detailed manufacturer's information for the drug used, especially in respect of structure quality (e. g., equipment and personnel requirements) must be followed.
Personal requirements
Recommendation: The physician who performs and is responsible for the sedation should be experienced in intensive care medicine. He or she should be trained and proficient in the use of sedatives. This includes knowledge, recognition, and treatment of expected side effects including cardiopulmonary resuscitation, freeing and maintaining open airways, intubation, and assisted ventilation. Recommendation grade A, evidence level 4, strong consensus Comment: As in the guidelines of other professional associations [10, 11, 21, 22, 35, 37, 41, 166, 187] , personal prerequisites for carrying out sedation analgesia include knowing how to deal with an emergency situation by correcting circulation problems and being proficient in endotracheal intubation.
Education and training courses
Recommendation: As part of quality assurance, physicians and nursing staff should receive special training in sedation.
Recommendation grade A, evidence level 4, strong consensus
Comments: So far, only isolated special training guidelines exist on premedication and management of emergency situations. These show that specific training, including in the form of simulation courses, improves physicians' confidence [188] . A much more extensive training program for nurses was the subject of several studies using propofol [14, 73] .
Personnel requirements 3.3.1 Education requirements
Recommendation: The qualification of physicians and nurses involved in sedation, monitoring, and follow-up should be ensured by periodical participation in structured further education curricula. In addition to theoretical knowledge, these curricula transmit practical competencies including complications management (e. g., in simulation training). In general, it is preferable for the whole endoscopy team (doctors and nurses) to do the training together. Recommendation grade A, evidence level 5, strong consensus
Sedation monitoring
Recommendation: The physician endoscopist is not usually able to pay adequate attention to the patient's vital functions during the procedure. For this reason, for every endoscopy under sedation it is necessary to have one person present in addition to the endoscopist and the assisting nurse, who is not involved in the intervention and who can fulfill this task reliably. This qualified person should be able to show proof of special training and experience in monitoring patients receiving sedatives, hypnotics, and/or analgesics. In all cases when a patient has an increased risk, or when a long, complex intervention is expected, a second physician qualified in resuscitation and intensive care should be present whose only task is the sedation and monitoring of the patient.
Recommendation grade A, evidence level 5, strong consensus
Comment: The guideline of the German Society for Anesthesiology and Intensive Care Medicine (Deutsche Gesellschaft für Anä-sthesiologie und Intensivmedizin, DGAI) [10] states: "Since the examiner is usually unable to watch the patient's vital functions with sufficient care while doing an endoscopy, it is necessary for a second, specially trained and qualified person to reliably take over the patient monitoring."
Recommendation:
The management of endoscopic sedation should take into account the patient's health, the invasiveness of the intervention, and the type of sedation being used. Table 12 ). NAPS should not be done for ASA grade IV -V patients [14 -17, 73] . NAPS should be performed by a person who is appropriately trained and has this as his or her sole task.
Restrictions on NAPS
Recommendation: For patients with an increased risk profile (see Section 1.4 on risk assessment), or for long, complex therapeutic interventions that require deep sedation and are thus associated with a higher sedation risk, a second physician who is experienced in intensive care medicine should perform the sedation. Recommendation grade A, evidence level 5, strong consensus
Monitoring after the endoscopic procedure
Recommendation: Patients should continue to be monitored with respect to their sedation after the examination is over.
Recommendation grade A, evidence level 5, strong consensus
Comment: Postinterventional monitoring is necessary to detect any sequelae of sedation. The duration of the postinterventional monitoring phase depends on the expected risk [20] . The duration of action and the half-life of the substance used should be taken into account. Close monitoring of the patient by qualified personnel should be continued, irrespective of the substance used, and using a pulse oximeter if thought desirable, until the patient has completely recovered. Patients can be released from the monitoring area when their vital signs are stable and they are oriented [10] . 
Facilities requirements
Recommendation: Sedation should only be carried out in a place that is adequately equipped for monitoring and support of respiratory and cardiovascular function. There should be an additional, separate recovery area. Recommendation grade A, evidence level 5, strong consensus
Comment: According to the DGAI guideline [10] : "the location and the equipment of the treatment and monitoring area should be geared to the needs of patients with relevant concomitant diseases (ASA grade III and higher). The recovery unit should be equipped for monitoring (pulse oximetry, blood pressure, ECG), with drugs, oxygen supply, and a pipeline outlet for suction, together with all the auxiliary material and equipment needed for resuscitation. In case of severe complications, suitable transport to a qualified treatment unit (e. g., intensive care unit) must be possible (e. g., an elevator large enough to take a bed)." Currently, no evidence-based data relating to the current recommendations and standards are available. A verdict of the German Supreme Court (reference no. VI ZR 265 / 02) criticized the seating of patients in the hall outside the treatment room after endoscopy under sedation. The recovery area must be defined as such and the patients must be under constant observation.
Equipment
Clinical monitoring / standard monitoring
Recommendation: Necessary monitoring measures include pulse oximetry and blood pressure measurement (especially for sedation with propofol). An ECG recording should be done for patients with severe heart disease. Recommendation grade A, evidence level 5, strong consensus
The person in charge of monitoring checks breathing clinically by observation, palpation of thorax and abdominal wall movement, and possibly palpation of the expiratory airstream. The endoscopy personnel must have appropriate emergency training and must be proficient in cardiopulmonary resuscitation. According to the recommendations of various national and international professional associations, pulse oximetry is required for monitoring after all examinations [9 -11, 19, 22, 37] . For sedated patients and high-risk patients, continuous blood pressure monitoring and an ECG lead are also demanded. In addition to clinical monitoring, pulse oximetry is required for sedation today (especially since the introduction of quality assurance agreements for colonoscopy in Germany). Oxygen saturation and heart rate are measured continuously. According to a survey in 2003, in Switzerland more than 95 % of endoscopies were monitored by pulse oximetry [190] . In international studies at European centers in 2006, 77 % of the colonoscopies were monitored with pulse oximetry [191] . A recent survey in Germany showed that pulse oximetry is used in 97 % of examinations [5] . For propofol sedation, blood pressure must also be monitored. The best monitoring devices show oxygen saturation, heart rate, and blood pressure on one screen that can be placed right next to the endoscopy monitor, so that the endoscopist can watch both. Documentation of the measurement parameters is desirable. Comment: During capnography the concentration of CO 2 in the breath is recorded using a nose mask. Breathing can be graphically displayed. Apnea can be diagnosed much earlier using this method than with pulse oximetry; this is especially important in pediatric interventions [192 -194] . In a prospective study by Vargo et al. [195] of 49 adults undergoing gastroscopy with therapeutic intent, twice as many apnea episodes were diagnosed by capnography than by pulse oximetry or clinical observation. In another prospective study by Anderson et al. [192] of 163 children, none of the apnea episodes that occurred in 24 % of the endoscopic procedures was diagnosed by pulse oximetry or clinical observation alone. In a retrospective study by Koniaris et al. [196] , 4846 patients were monitored without and 600 patients with capnography during endoscopy. In the patient group not monitored with capnography there was a tendency toward oversedation, especially in older patients and those undergoing long examinations, although it was not significant. In the capnography group no case of oversedation was reported.
No data are available regarding clinical endpoints (e. g., severe hypoventilation with clinical consequences) when capnography is not used in gastrointestinal endoscopy. On the basis of currently available data, routine use of capnography generally cannot be recommended.
EEG monitoring
Recommendation: The benefit of EEG monitoring with respect to relevant parameters in gastrointestinal endoscopy has not been demonstrated. Recommendation grade 0, evidence level 1b, strong consensus Comment: Bispectral monitoring is used to evaluate sedation depth in intensive care medicine and in surgical patients. A pilot study described bispectral monitoring as part of a closed monitoring cycle for the continuous infusion of propofol in 16 patients sedated for colonoscopy [84] . In another randomized controlled study by Wehrmann et al. [115] a significant reduction of the propofol dose was shown when another EEG monitoring technique was used for ERCP. Bispectral monitoring cannot be recommended for gastrointestinal endoscopy, especially for short examinations such as colonoscopy, because according to existing study data [197, 198] no reduction in propofol dose was achieved, and therefore neither the recovery time shortened. 
General and legal aspects
The adjudication on medical interventions, the physician's duty to inform, and patient information is very complex. According to permanent adjudication of the German Federal Supreme Court, every medical intervention constitutes a personal injury offense according to paragraph 223 ff. StGB, 823 I BGB. Medical interventions include not just the performance of diagnostic procedures but also of therapeutic measures such as operations or the administration of drugs [199] . The consent ("informed consent") that is necessary for these procedures is only valid if the patients have been given sufficient information and are competent to exercise their right to self-determination.
If patients are not competent to give their consent (e. g., children, severely mentally retarded persons), the physician must give the information to their representative (guardian, agent for health care matters, or other person responsible) [200, 201] .
To be competent to give their consent, patients must also be able to understand the implications of the intervention. Aside from the legal background, a well-performed consent procedure with information and explanation increases patient satisfaction [37] . Patients should receive the information even if they have already undergone a similar endoscopic intervention and they claim to have been given plenty of information the first time. Many patients are not good judges of their own level of information and understanding. Moreover, information received earlier may have been forgotten or details remain misunderstood.
Informing person
Recommendation: A competent and experienced physician should provide information about the procedure to the patient in a form he or she can understand. Recommendation grade A, evidence level 5, strong consensus
Comments: The physician must be competent and experienced in sedation. Informing the patient, who is usually uneducated in medicine, must be done gently and comprehensibly. It is important that the patient understands the impact and implications of the intervention, and the physician must make quite sure that the patient does have this understanding. Delegation, e. g. to a nurse, is not permissible by law in Germany.
Informed consent procedure
Recommendation: The foundation of the consent procedure should be a discussion between the physician and patient. The content and range of the discussion should be documented. The patient should receive the information in good time.
Recommendation grade A, evidence level 5, strong consensus
Comments: The information about and discussion of the proposed procedure must be conducted in a patient-centered manner, i. e., dependent on the patient's ability to comprehend and on how much information he or she wants. Standardized patient information forms can be used in addition to help convey the information and for documentation purposes, but they are not a substitute for the personal discussion. Written documentation is essential, because according to civil law physicians have to be able to prove that the consent procedure was followed correctly [199] . The extent of the consent procedure is in inverse proportion to the urgency of the intervention. Patients should not be told that they may waive their right to information, and should certainly not be urged to do so. However, if they refuse the information of their own accord, this refusal should be documented and signed by the patient [201, 202] . The importance of the patient's right to decide dictates that they should have enough time to give their consent before the procedure, and this involves an informed consent process that starts early enough for their decision to be made without time pressure. The right time for the information interview depends on the individual situation. Even in an emergency, responsive patients should have as much explained to them as time permits before giving their consent [202] .
Altogether, the information procedure should proceed as soon as possible; ideally it should be started when the appointment for the endoscopic intervention is made [202] .
Content of the patient information interview
Recommendation: The discussion should include information on the preparation for sedation, various sedation methods, and their possible complications. It should also include making the patient aware that it is possible to carry out the intervention without sedation. Recommendation grade A, evidence level 5, strong consensus
Comments: In almost all interventions, adverse effects of sedation are responsible for at least 50 % of complications [203] . Complications of sedation (aspiration, arterial hypotension, bradycardia, apnea, etc.) are therefore typical complications and must be discussed with the patient in detail. The patient should be told about the typical sedation risks irrespective of complication rates. Severe atypical risks must also be discussed. At the same time the discussion should be gentle; the patient must not be frightened with exaggerated risk information. The physician should advise the patient on the "if and how" of sedation. In addition to sex and age, it is wise to take into account the patient's level of anxiety/fear when setting the sedation dose, because these three factors have been shown to predict the patient's cooperation during the intervention, and on his or her satisfaction afterwards [105, 204, 205] . On the whole, younger and more anxious patients and women should tend to be advised to choose sedation [20, 27, 30, 48, 105] . However, as sedation usually seems necessary to avoid unwanted involuntary patient movement, especially during long examinations and difficult interventions (e. g., ERCP, difficult polypectomy), this too should be explained to the patient [11, 23, 91, 206] . If the patient suffers injury after withholding consent to a necessary intervention as a result of an information interview that was too "tough," the physician is responsible [207] . Sedation can be refused if either the patient is in too high an ASA risk class [37] , or if the hospital and personnel are not adequately equipped to perform sedation to the required standard. The physician must then explain to the patient why sedation is not possible.
Whether patients should be informed of the possibility of dying as a result of the intervention is debated. In two judgments of the Regional Appeal Court Stuttgart, Germany [207, 208] and one of the Regional Appeal Court Zweibrücken, Germany [209] it was required that the patient be gently informed before colonoscopy of the possibility of dying as a result of perforation. In another case, it was required that the patient be informed that she could die as a consequence of an ERCP.
Safety information (patient do's and don'ts after endoscopic sedation)
Recommendation: Patients should be told about what it is safe for them to do or not to do after sedation and discharge from outpatient treatment, and should be given an information leaflet. Recommendation grade A, evidence level 5, strong consensus
Comments: Patients undergoing endoscopy as an outpatient procedure should be told that they need to bring someone who at least will accompany them home safely and also, if possible, keep them under observation for a few hours. In addition, all patients who are sedated must be told that they must not be out in road traffic, operate complicated machinery, drink alcohol, or make important or legally binding decisions. Patients should always be given a telephone number to contact the physician or hospital if they feel unwell or have bleeding after the endoscopy [11, 23, 201] . The patient should be given the information on do's and don'ts for the period after the examination in written form and in person [11, 201, 202] . For critical procedures or patients, a telephone call the next day is more effective than a written reminder [210] .
Requirements for carrying out sedation
Recommendation: A permanent intravenous access is required for sedation. Recommendation grade A, evidence level 2b, strong consensus Comment: Peripheral venous access is a fundamental requirement for the administration of sedatives. A comparative study by Smith et al. [211] investigated the functionality of butterfly and indwelling catheters 1 hour after endoscopy, a time when most benzodiazepines and opiates have not even reached their half-life. Only 44 % of the butterflies but 98 % of the indwelling catheters were still functional.
Protection of vital functions
Recommendation: Sedated patients should receive oxygen prophylactically via a nasal tube. Recommendation grade A, evidence level 2b, strong consensus Comment: Incidents due to sedation are usually cardiopulmonary events [203] . These make up about half of all complications in endoscopy, and depending on the patient's risk level can also occur during gastroscopy without sedation [212] . Earlier publications reported a 5 % incidence of cardiopulmonary events with benzodiazepine use [124] . In more recent studies using propofol, the rate was between 0.0 % and 0.65 %, and in a large observational study on colonoscopy screening in Germany it was 0.1 %. Eighty percent of the examinations in this study were done under sedation, but the drug was not specified [213] . Older patients in particular are at risk of hypoxia under sedation [13, 103] . Prophylactic oxygen administration via a nasal tube can significantly reduce the frequency of hypoxemic events [214 -216] . However, there are also indications that prophylactic oxygen administration can delay the early detection of hypoxemic events using pulse oximetry [20] .
4. 
Cardiac arrhythmias
General
Endoscopic intubation of the colon is enough by itself to cause excessive activation of the sympathetic autoregulative nervous system in unsedated patients [217] , thus increasing the probability of cardiovascular events. The influence on heart rate variability is enhanced further by sedation [218] . However, cardiopulmonary events can also be observed in unsedated patients during gastroscopy [140] .
Tachyarrhythmia
There are no reports in the literature on tachycardia requiring intervention, only on frequent supraventricular and ventricular extrasystoles [219] . In emergencies, class Ia -IV antiarrhythmics should be given intravenously and a defibrillator should be kept at hand according to the guidelines of the cardiological professional associations [220] .
Bradyarrhythmia
Occasionally bradycardia occurs, especially during colonoscopy with or without sedation. The incidence is reported at 0.5 % [189] . However, drug intervention was only necessary in one third of the patients. The intervention consists of giving 0.5 mg atropine intravenously, repeated if necessary up to a dose of 3 mg, and/or adrenaline 0.02 -0.1 mg intravenously. In lifethreatening situations resuscitation with heart massage should be done [220] .
Arterial hypotension
The incidence of arterial hypotension during colonoscopy varies between 0.3 % [189] and 3 % -19 % depending on the definition [217] . The intervention for arterial hypotension is an infusion of physiological saline solution. Prophylactic infusion in all colonoscopies is not recommended [221] , but may well be a good choice in older dehydrated patients. Prophylactic intravenous administration of fluids can also be useful for long procedures carried out under propofol sedation, because of the pronounced bloodpressure-reducing properties of propofol.
Myocardial ischemia
Myocardial ischemia can occur during endoscopy with or without sedation. In a prospective study ST-segment depression was described in 7 % of patients undergoing colonoscopy. Three-quarters of these events occurred before the actual endoscopy [222] . ST depression can be significantly reduced by oxygen supplementation during endoscopy [216] . There is one published report of a case of heart attack during colonoscopy [155] .
Rare events during sedation
Allergies and local pain reactions (usually related to injections into small veins) are occasionally seen during endoscopy of sedated patients. In 80 000 colonoscopies, one allergic reaction to midazolam was observed [205] . Allergic reactions to soy protein have been observed after propofol injection (see Section 2.2.1.1). The drugs required to manage allergic reactions (e. g., adrenaline, cortisone, antihistamines) should be readily available in the endoscopy unit.
5 Quality goals: internal quality assurance/discharge criteria/fitness for road traffic/ability to work/documentation/ benchmarking ! To achieve high-quality outcomes in a process, it is necessary to define and comply with quality goals. Moderation of the process of development of quality measurement procedures follows a fixed structured course and starts with definition of the quality goals. Quality goals can relate to patient care or to the outcome of treatment. In the international literature an "indicator statement" is often given instead of a quality goal. The first stage is completion of the half-sentence: "Good quality is when…"
" Patients are able to decide for themselves for or against sedation on the basis of an optimal patient information process.
" Patients undergoing gastrointestinal endoscopy receive appropriate sedation adapted to their individual needs and health.
" A high rate of patient acceptance for endoscopic examinations is reached, especially in screening programs.
" Endoscopists have optimal examination conditions because of the sedation.
" Patients have no complications because they are appropriately monitored during sedation, and patient safety is high because the incidence of sedation-related complications is minimized.
" If unforeseen complications occur, patients can be treated quickly and carefully according to the rules of medicine.
" Patients are adequately cared for until discharged.
" Patients are not discharged until any severe impairments caused by the drug that have not completely subsided are no longer detectable. The abovelisted points are intended to contribute to optimization and compliance with the defined quality goals. Since this is the first version of the S3 guideline on sedation for gastrointestinal endoscopy, and the data available on this topic are very limited, explicit indicators with reference ranges beyond the quality goals have not yet been defined. To investigate whether the quality goals recommended here are already in effect, the guideline group decided that comprehensive data should be collected from practical experience in patient care. These results will be used to establish more specific quality indicators according to the BQS procedures [see , Federal Office for Quality Assurance (Bundesgeschäftsstelle für Qualitätssicher-ung)] as part of the updating process.
Internal quality assurance
Recommendation: There should be a written and easily comprehensible procedure plan for carrying out sedation, monitoring the patient after sedation, the criteria for discharge to the outpatient or general inpatient area, and the management of any complications. The respective responsibilities should be clearly defined. 
Minimum criteria for discharge
Recommendation: The minimum criteria for discharge (according to the Report of the Working Party on Guidelines for Sedation by Non-Anesthetists [224] ) should be met and documented. Recommendation grade A, evidence level 5, strong consensus (• " Table 13) 5.2.3 Use of score systems for discharge Recommendation: Score systems (e. g., Aldrete score) should not be the sole basis for decisions as to whether patients can be discharged, because they do not evaluate psychomotor function. Recommendation grade B, evidence level 2b, strong consensus Comment: The use of a modified Aldrete score [225] allows statements only about patients' vital functions, but not about their psychomotor performance, which may be considerably impaired even when a maximum score is obtained [226] . Table 13 Minimum criteria for patient discharge after sedated endoscopy (according to [224] ). Even if patients have stable vital signs and seem sufficiently awake after sedation, it is known that after the use of intermediate-acting substances (e. g., midazolam, pethidine) patients have a prolonged phase of amnesia and impairment of reflexes and judgment. Patients undergoing colonoscopy who are sedated with frequently employed combination of midazolam plus opiate show impairments of reaction time, fine motor skills, and perception for at least 30 minutes after the procedure. Study data show that the remaining after-effects of midazolam impair various aspects of psychomotor function for at least 1 hour after administration [226, 227] . Midazolam seems in these cases to be the main reason for the persistent impairment of psychomotor function after sedation [228] . A study by Thapar et al. [228] comparing the effect of midazolam with fentanyl and propofol gave similar results.
Fitness for road traffic
Recommendation: Whether a patient is fit for road traffic, whether as an active (i. e., driving) or a passive participant (i. e., using public transportation), should be decided at the time of discharge taking into account the half-life of the drug used and the individual patient's risk profile. Recommendation grade A, evidence level 1b, strong consensus Comment: The normalization of psychomotor function on the day of the examination is essentially dependent on the half-life of the substance used. Short-acting substances have an advantage in this respect. A study by Riphaus et al. [8] of 98 patients compared sedation with propofol versus midazolam/pethidine for gastroscopy and colonoscopy. Compared to midazolam/pethidine, no impairment of psychomotor function (tested using a driving simulator) was seen 2 hours after sedation with propofol. After the use of short-acting hypnotics (e. g., propofol), fitness to use the roads seems to be restored when the half-life is reached. Nonetheless, because the number of patients in this study was small, the most that is considered possible is the use of public transport (including without an accompanying person). Much larger field studies are necessary for decisions about riding a bicycle or driving a car. The currently valid recommendation of the various professional associations [9 -11] to neither drive a vehicle nor use public transport for 24 hours seems too strict considering that there is no evidence to support the choice of this time period, especially in relation to the ultra-short-acting substances such as propofol and remifentanil. A whole series of studies by Korttila et al. [229 -231] dating back to the 1970s investigated psychomotor function after sedation with various drugs. These showed that even when benzodiazepines were used at higher doses (diazepam 0.45 mg/kg b. w.), psychomotor functions were restored after 10 hours [230] . Only when pethidine 75 mg i. m. was used were psychomotor functions impaired for up to 12 hours, and in this case the recommendation not to drive for 24 hours seems justifiable -but pethidine 75 mg i. m. is no longer routinely used in endoscopy [229] .
Documentation
Recommendation: The patient file or the documentation form should contain time-dependent documentation of the vital signs (oxygen saturation, heart rate, and blood pressure), the drugs used including name and dose, the administration of intravenous fluids, and whether and at what flow rate the patient received oxygen. Ideally, the degree of sedation grade and patient's statements about pain experienced should also be periodically documented. Recommendation grade A, evidence level 5, strong consensus
General
Documentation is an essential part of patient care and should be done in all phases of the intervention. These include:
" Preintervention evaluation of the patient " Giving the patient all relevant information about the intervention " Monitoring during the intervention " Patient recovery " Patient discharge Ideally, a standardized documentation form should be used, because this improves documentation compliance [232] .
Inability to work
Recommendation: The time for which a person is unfit for work is judged on an individual basis taking account of the nature of the workplace, the duration and depth of sedation, and the drug used.
Recommendation grade 0, evidence level 5, consensus
Comment: A general recommendation cannot be given on how long a patient is unfit for work after the use of sedatives and analgesics for gastrointestinal endoscopy. The usual recommendation of 24 hours after sedation can be viewed as too long when short-acting drugs have been used.
Benchmarking
Recommendation: All complications (drop in oxygen saturation, hypotension, mask ventilation, intubation, and death) that occur during endoscopy with or without sedation should be documented. Systematic overview of well-planned cohort studies A well-planned cohort study or an RCT of poor quality Outcome studies, ecological studies 3a 3b
Systematic overview of case-control studies A case-control study 
